Michael Krawitz

Last updated

Michael Krawitz (4th from the left) with the leadership of FAAAT at the Vienna International Centre in 2018. The leadership of FAAAT think & do tank during the closure of the International Cannabis Policy Conference 2018.jpg
Michael Krawitz (4th from the left) with the leadership of FAAAT at the Vienna International Centre in 2018.

Michael Alan Krawitz is a US Air force veteran, [1] Executive Director of the non-profit Veterans for Medical Cannabis Access, [2] researcher on the history of medical cannabis, and international advocate for cannabis policy reform [3] with FAAAT think & do tank and the International Association for Cannabinoid Medicines. [4]

Contents

Biography

Krawitz served in the United States Air Force from 1981 to 1986 as an Electronic Warfare Systems Technician and was a sergeant. [1] He was stationed in Guam.

Apart from his military career, Krawitz has been involved in the United States, [5] researching the traditions and historicity of cannabis in the country, [6] as well as working to secure access and availability of medical cannabis [7] for veterans, [8] in particular with the United States Department of Veterans Affairs [9] [10] and has extended its involvement at the international level since the United Nations General Assembly Special Session on the world drug situation in 1998 throughout the 2020s. [11]

Internationally he has been involved in the New-York NGO Committee on Drugs as Executive Committee member, [12] as patient representative of the International Association for Cannabinoid Medicines. [4] Krawitz is also policy adviser of the organization FAAAT think & do tank [13] for his involvement around the World Health Organization [14] [15] [16] and Single Convention on Narcotic Drugs international scheduling of Cannabis, [17] [18] being instrumental in the efforts leading to the withdrawal of "cannabis and cannabis resin" from Schedule IV of the 1961 Convention, in December 2020. [19] [20] [21] [22]

Krawitz is also working on the creation of Appellation of Origin and other intellectual property tools for traditional Cannabis products, [23] both in the United States, participating as a board member of the Californian farmers organization Origins Council, [24] and internationally as a registered observer to the World Intellectual Property Organization. [25]

Since 2021, he has been member of board of advisors to the Virginia Cannabis Control Authority (Cannabis Public Health Advisory Council). [26]

Publications

Related Research Articles

<span class="mw-page-title-main">Medical cannabis</span> Marijuana used medicinally

Medical cannabis, or medical marijuana (MMJ), is cannabis and cannabinoids that are prescribed by physicians for their patients. The use of cannabis as medicine has not been rigorously tested due to production and governmental restrictions, resulting in limited clinical research to define the safety and efficacy of using cannabis to treat diseases.

<span class="mw-page-title-main">Removal of cannabis from Schedule I of the Controlled Substances Act</span> Proposed changes to the legal status of cannabis in U.S. federal law

In the United States, the removal of cannabis from Schedule I of the Controlled Substances Act is a proposed legal and administrative change in cannabis-related law at the federal level. It has been proposed repeatedly since 1972. The category is the most tightly restricted category reserved for drugs that have "no currently accepted medical use."

<span class="mw-page-title-main">Single Convention on Narcotic Drugs</span> 1961 international treaty regulating narcotic drugs

The Single Convention on Narcotic Drugs, 1961 is an international treaty that controls activities of specific narcotic drugs and lays down a system of regulations for their medical and scientific uses; it also establishes the International Narcotics Control Board.

<span class="mw-page-title-main">United Nations Commission on Narcotic Drugs</span> Central drug policy-making body of the UN System

The Commission on Narcotic Drugs (CND) is one of the functional commissions of the United Nations' Economic and Social Council (ECOSOC), and is the central drug policy-making body within the United Nations System. The CND also has important mandates under the three international drug control conventions, alongside the three other treaty-mandated bodies: United Nations Office on Drugs and Crime, World Health Organization, and International Narcotics Control Board.

<span class="mw-page-title-main">Cannabis Social Club</span> Non-profit industry model for recreational cannabis

A Cannabis Social Club (CSC), sometimes called Cannabis Club, Cannabis Association, or Teapad, is an industry model for regulated cannabis organised as non-profit cooperatives in which cannabis is cultivated, shared, and enjoyed collectively, usually for the purpose of relaxing or for social communion.

<span class="mw-page-title-main">Veterans for Medical Cannabis Access</span>

Veterans for Medical Cannabis Access (VMCA), which was founded as Veterans for Medical Marijuana Access (VMMA) reflecting the pejorative word "marijuana", is an Elliston, Virginia-based non-profit service organization designed to assist American veterans who wish to be able to use marijuana for medical purposes with a doctor's recommendation. VMCA works towards the freedom for veterans to discuss the medical use of marijuana with their doctors without the risk of reprisal.

<span class="mw-page-title-main">International Office of Public Hygiene</span> Predecessor to the World Health Organization

The International Office of Public Hygiene (OIPH), also known by its French name as the Office International d'Hygiène Publique (OIHP), was an international organization founded 9 December 1907 and based in Paris, France. It merged into the World Health Organization after World War II.

<span class="mw-page-title-main">Dronabinol</span> Generic name of Δ9-THC in medicine

The International Nonproprietary Name dronabinol, also known under the trade names Marinol and Syndros is a generic name for the molecule of delta-9-tetrahydrocannabinol in the pharmaceutical context. It has indications as an appetite stimulant, antiemetic, and sleep apnea reliever and is approved by the FDA as safe and effective for HIV/AIDS-induced anorexia and chemotherapy-induced nausea and vomiting only.

The list includes and details significant events that occurred in the global history of national-level implementations of, or changes made to, laws surrounding the use, sale, or production of the psychoactive drug cannabis.

<span class="mw-page-title-main">Cannabis in China</span> Use of cannabis in China

Cannabis is illegal in China except for industrial purposes (hemp) and some forms of medicine. Historically, cannabis has been used in China for fiber, seeds, as a traditional medicine, as well as for some ritual purposes within Taoism.

<span class="mw-page-title-main">NORML France</span>

NORML France, previously known as Chanvre & Libertés - NORML France is a French non-profit organization based in Toulouse but active in all territories of France, whose aim is to move public opinion sufficiently to achieve the depenalization of illicit drugs consumption, the legalization of non-medical marijuana and the increased access to medical cannabis in France, so that the responsible use of cannabis by adults is no longer subject to penalty.

<span class="mw-page-title-main">History of cannabis</span> Aspect of history

The history of cannabis and its usage by humans dates back to at least the third millennium BC in written history, and possibly as far back as the Pre-Pottery Neolithic B based on archaeological evidence. For millennia, the plant has been valued for its use for fiber and rope, as food and medicine, and for its psychoactive properties for religious and recreational use.

<span class="mw-page-title-main">Cannabis and international law</span>

The status of cannabis in international law is a century-old history. Cannabis reform at the international level refers, in the 20th century, to efforts to increase restrictions on cannabis use under international treaties; in the 21st century, generally to efforts to ease or update such restrictions.

<span class="mw-page-title-main">Camille Barrère</span> French diplomat

Camille Barrère was a French diplomat, most notably the ambassador to Italy from 1897 to 1924.

<span class="mw-page-title-main">FAAAT think & do tank</span> Global think tank on drug policy reform

For Alternative Approaches to Addiction, Think & do tank is an international non-profit organization working on drug policy, created in 2015 and based in Paris, France.

This is a social history of the 2020s. Social history refers to changes affecting societies and the lived experiences of their members.

The International Association for Cannabinoid Medicines (IACM), formerly known as the International Association for Cannabis as a Medicine, is a non-profit scientific society founded in Cologne in 2000 and dedicated to the advancement of knowledge of cannabis and cannabinoid medicines among medical professionals. IACM is one of the few global non-profit medical societies or associations related to cannabis and Cannabinoids, along with the Society of Cannabis Clinicians and the International Cannabinoid Research Society.

The removal of cannabis and cannabis resin from Schedule IV of the Single Convention on narcotic drugs, 1961 is a change in international law that took place in 2021, on the basis of a scientific assessment by the World Health Organization.

<span class="mw-page-title-main">Horizontal Working Party on Drugs</span> Body of the Council of the European Union

The Horizontal Working Party on Drugs is a preparatory body of the Council of the European Union established in 1997, responsible for the lead and management of the work of the council and of the European Union (EU) on drug policy.

<span class="mw-page-title-main">Farid Ghehiouèche</span> French cannabis activist

Farid Ghehiouèche is a French author, activist and politician, known for his involvement for cannabis and other drugs liberalization, and in pacifist, ecologist, freedom of speech, gender equality, right of asylum and prison abolition social movements. He has been active since the 1990s in France and in international organizations.

References

  1. 1 2 Rick Schettino (August 12, 2018). "Michael Krawitz leaves no soldier behind: The Executive Director of Veterans for Medical Cannabis Access on VA and federal marijuana policies". Pot Network. Retrieved February 8, 2019.
  2. Bryce Crawford (July 29, 2010). "MMJ believers embrace Veterans Affairs' new stance". Colorado Springs Independent . Retrieved February 7, 2019.
  3. "The High Times Interview: Michael Krawitz". High Times. January 2, 2015. Retrieved February 25, 2022.
  4. 1 2 Grotenhermen, Franjo; Müller-Vahl, Kirsten R. (April 15, 2021). "Two Decades of the International Association for Cannabinoid Medicines: 20 Years of Supporting Research and Activities Toward the Medicinal Use of Cannabis and Cannabinoids". Cannabis and Cannabinoid Research. 6 (2): 82–87. doi:10.1089/can.2020.0044. ISSN   2578-5125. PMC   8064956 . PMID   33912675.
  5. "Veterans are key as surge of states OK medical pot for PTSD". The Washington Times. Associated Press. November 26, 2017. Retrieved February 8, 2019.
  6. Mary Mathre & Michael Krawitz (2012). "Cannabis series ‐ the whole story Part 4: The medicinal use of Cannabis pre‐prohibition". Drugs and Alcohol Today . 2 (2): 3–7. doi:10.1108/17459265200200010.
  7. Cal Woodward (September 21, 2010). "United States war veterans gain access to medicinal marijuana. CMAJ September 21, 2010 182 (13) 1405–1406; DOI: doi.org/10.1503/cmaj.109-3334". Canadian Medical Association Journal. 182 (13): 1405–6. doi: 10.1503/cmaj.109-3334 . PMC   2942910 . PMID   20713581.
  8. Ocean Malandra (February 4, 2019). "Cannabis Provides Relief for Vets, Assault Victims With PTSD". Weedmaps News. Retrieved February 8, 2019.
  9. Dan Frosch (July 23, 2010). "V.A. Easing Rules for Users of Medical Marijuana". The New York Times . Retrieved February 7, 2019.
  10. Michael Krawitz (June 17, 2015). "Veterans Health Administration Policy on Cannabis as an Adjunct to Pain Treatment with Opiates". AMA Journal of Ethics . 17 (6): 558–61. doi: 10.1001/journalofethics.2015.17.6.pfor2-1506 . PMID   26075984 . Retrieved February 8, 2019.
  11. International Association for Cannabinoid Medicines (March 16, 2022). "IACM on LinkedIn: Today the IACM Patient Council had the opportunity to share their work and debate about the actual situation in UN - CND (United Nations Commission on Narcotic Drugs)". www.linkedin.com. Retrieved March 24, 2022.
  12. New York NGO Committee on Drugs (2016). "Collection of member organization submissions to UNGASS" (PDF). United Nations Office on Drugs and Crime . Retrieved February 8, 2019.
  13. Susan Mayor (February 5, 2019). "WHO proposes rescheduling cannabis to allow medical applications". British Medical Journal. 364: l574. doi:10.1136/bmj.l574. PMID   30723076. S2CID   73449383 . Retrieved February 7, 2019.
  14. Michael Krawitz (November 16, 2015). "Statement of Michael Krawitz as delivered to the World Health Organization, Expert Committee on Drug Dependence, 16 November 2015" (PDF). World Health Organization . Retrieved February 8, 2019.
  15. Aristos Georgiou (February 8, 2019). "WHO RECOMMENDS RESCHEDULING CANNABIS IN INTERNATIONAL LAW FOR FIRST TIME IN HISTORY". Newsweek . Retrieved February 9, 2019.
  16. Riboulet-Zemouli, Kenzi; Krawitz, Michael Alan (January 1, 2022). "WHO's first scientific review of medicinal Cannabis: from global struggle to patient implications". Drugs, Habits and Social Policy. 23: 5–21. doi:10.1108/DHS-11-2021-0060. ISSN   2752-6747. S2CID   247421561.
  17. Tom Angell (February 1, 2019). "World Health Organization Recommends Reclassifying Marijuana Under International Treaties". Forbes. Retrieved February 7, 2019.
  18. Redaction (February 1, 2019). "OMS quer classificação mais branda para maconha em tratados internacionais". Globo. Retrieved February 8, 2019.
  19. Isabella Kwai (December 2, 2020). "U.N. Reclassifies Cannabis as a Less Dangerous Drug". New York Times . Retrieved December 2, 2020.
  20. Robert Hoban (December 3, 2020). "The United Nations Reclassifies Cannabis Clearing Path For Global Industry". Forbes . Retrieved December 5, 2020.
  21. Budryk, Zack (December 2, 2020). "United Nations commission votes to remove marijuana from list of most dangerous drugs". The Hill.
  22. Riboulet-Zemouli, Kenzi; Krawitz, Michael; Ghehiouèche, Farid (2021). History, science, and politics of international cannabis scheduling, 2015–2021. Vienna: FAAAT editions. ISBN   979-10-97087-50-0.
  23. "The Importance of Appellations of Origin to the Successful Therapeutic Model of Whole Plant Cannabis". ICFA Programs > Advocacy. International Cannabis farmers Association. Retrieved July 27, 2020.
  24. "About Us". Origins Council. Origins Council. Retrieved July 27, 2020.
  25. "REPORT adopted by the Committee" (PDF). WIPO Committee on Development and Intellectual Property (CDIP). Geneva. Twenty-Third Session. May 20–24, 2019. Retrieved July 27, 2020.
  26. Cannabis Control Authority, Board of Directors. "Meeting - MINUTES - Dec. 8, 2021". studies.virginiageneralassembly.gov. Retrieved February 25, 2022.